Clinical Trials Browser

Phase 1 × serabelisib × 1 year × Clear all

NCT05300048 2025-10-06

Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumor